maprotiline has been researched along with lofepramine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Finke, G; Wegener, G | 1 |
Graf, U; van Schaik, N | 1 |
Kodama, Y; Nomura, S; Shimizu, K; Watanabe, M | 1 |
1 trial(s) available for maprotiline and lofepramine
Article | Year |
---|---|
[Comparison of the therapeutic effects of lofepramine and maprotiline in depression].
Topics: Anthracenes; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Humans; Lofepramine; Maprotiline | 1982 |
6 other study(ies) available for maprotiline and lofepramine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Structure-activity relationships of tricyclic antidepressants and related compounds in the wing somatic mutation and recombination test of Drosophila melanogaster.
Topics: Animals; Antidepressive Agents, Tricyclic; Chlorpromazine; CHO Cells; Clomipramine; Cricetinae; Drosophila melanogaster; Female; Lofepramine; Male; Maprotiline; Mianserin; Mutagenicity Tests; Mutagens; Recombination, Genetic; Structure-Activity Relationship | 1993 |
[A case of allergic cross reaction between tricyclic antidepressants and maprotiline].
Topics: Aged; Amoxapine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross Reactions; Depression; Drug Eruptions; Female; Humans; Lofepramine; Maprotiline | 1998 |